Acadia Pharmaceuticals
ACAD
ACAD
225 hedge funds and large institutions have $3.5B invested in Acadia Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 84 increasing their positions, 69 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 232 → 225 (-7)
6% less capital invested
Capital invested by funds: $3.73B → $3.5B (-$235M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
225
Holding in Top 10
5
Calls
$103M
Puts
$96.5M
Top Buyers
| 1 | +$50.9M | |
| 2 | +$39.6M | |
| 3 | +$33M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$32.3M |
| 5 |
SIG
Senator Investment Group
New York
|
+$24.5M |
Top Sellers
| 1 | -$31.2M | |
| 2 | -$30.6M | |
| 3 | -$25.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.4M |
| 5 |
VanEck Associates
New York
|
-$17M |